Medical Breakthroughs Reported by Ivanhoe.com. Click here to go to the homepage.
Be the First to Know. Click here to subscribe FREE!
Search Reports: Use quotation marks around your multi-word search terms in the box below to perform search of Ivanhoe.com.
Advances in health and medicine.Use " marks around search terms
 
What's New
News Flash
Discussion
healthchannelnews
  Alternative Health
Arthritis
Asthma & Allergies
Autism
Breast Cancer
Cancer
Cardiovascular Health
Children's Health
Dental Health
Diabetes
Fertility & Pregnancy
Men's Health
Mental Health
Multiple Sclerosis
Neurological Disorders
Nutrition & Wellness
Orthopedics
Pet Health
Robotics
Seniors' Health
Sports Medicine
Vision
Women's Health
Advances in health and medicine.
Click here to sign up for Medical Alerts!
Click below to access other news from Ivanhoe Broadcast News.
  Click here to get Ivanhoe's Medical Headline RSS feed Click here to listen to Ivanhoe's Medical Podcasts
Useful Links
Play It Again, Please
E-Mail a Friend
Order Books Online
Inside Science
Smart Woman
Advances in health and medicine.
Smart Woman Home
Click here to read the story
Click here to read the story
Click here to read the story
Smart Woman Home
Advances in health and medicine.
Click below to learn about Ivanhoe.
  Awards
About Us
Contact Us
Employment
Feedback
Ivanhoe FAQ
Our TV Partners
Travel Calendar
Advances in health and medicine.
Ivanhoe celebrates 20 years of medical news reporting reaching nearly 80 million TV households each week. Click here to learn more...
Advances in health and medicine.
Marjorie Bekaert Thomas
Publisher/President
Advances in health and medicine.
Advertisement
Diabetes Channel
Reported January 29, 2013

“Jelly” Drugs for Better Delivery

 

(Ivanhoe Newswire) – More than 40 peptide drugs are approved and more than 650 are being testing in clinical studies for treating diseases such as diabetes and cancer.  Researchers at Duke University have developed a new delivery system that overcomes the peptide drugs’ shortcomings.  
 
Peptide drugs are very small proteins.  An example is the hormone insulin.  It is a peptide that regulates the metabolism of carbohydrates in the body and is used as a drug to treat diabetes.  
 
Peptide drugs are mostly effective, but they cannot achieve their full potential.  They are rapidly degraded in the blood stream and are cleared from the body, which will result in multiple, frequent injections.  This will cause peptide concentrations in the blood to rise after injection and fall dramatically soon after, resulting in unwanted side effects for the patient.
 
A popular method to solve this problem involves loading peptide drugs into polymer microspheres that are injected under the skin and slowly degrade to release the peptide drugs.  This technology has been proven useful, but has issues related to manufacturing.
 
 "We wanted to know if we could create a system that does what the polymer microspheres do, but gets rid of the microspheres and is more patient-friendly," Ashutosh Chilkoti, Theo Pilkington professor of biomedical engineering in Duke’s Pratt School of Engineering, was quoted as saying.
 
The new approach will involve making a “fusion protein,” which has multiple copies of a peptide drug fused to a polymer that is sensitive to body heat.  The fusion molecule is a liquid, but transforms into a “jelly” when it is injected underneath the skin.  Enzymes will begin to attack the drug and liberate copies of the peptide, providing a constant and controlled release of the drug.
 
Former graduate student and first author, Miriam Amiram said the new delivery system should be for protease-operated depot (POD).  In the latest experiments, researchers fused glucagon-like peptide-1 (GLP-1), a regulating hormone, with a genetically engineered heat-sensitive polymer to create the POD.  
 
"Remarkably, a single injection of the GLP-1 POD was able to reduce blood glucose levels in mice for up to five days, which is 120 times longer than an injection of the peptide alone.  For a patient with type 2 diabetes, it would be much more desirable to inject such a drug once a week or once a month rather than once or twice a day. 
 
Additionally, this approach avoids the peaks and valleys of drug concentrations that these patients often experience.  This new delivery system provides the first entirely genetically encoded alternative to peptide drug encapsulation for sustained delivery of peptide drugs," Chilkoti concluded.  
 
SOURCE:  Journal Proceedings of the National Academy of Sciences, January 2013
 

 

Related Articles in Latest Medical News:

[ Back to Diabetes Channel Home ]

MEDICAL ALERT!
Stay up to date on Diabetes. We can notify you every time there is a medical breakthrough. Click here to sign up.
EDITOR'S CHOICE
Most Recent Videos

Follow Us On:

Click here to go to Ivanhoe's Twitter page Click here to go to Ivanhoe's Facebook page Click here to go to Ivanhoe's YouTube page
Advertisement

Home | What's New | News Flash | Search/Latest Medical News | E-Mail Medical Alerts!
Ivanhoe FAQ | Privacy Policy | Our TV Partners | Awards | Useful Links | Play It Again, Please
RSS Feeds | Advertising/Sponsorships | Content Syndication | Reprints

Advances in health and medicine.
webdoctor@ivanhoe.com
Copyright © 2014 Ivanhoe Broadcast News, Inc.
2745 West Fairbanks Avenue
Winter Park, Florida 32789
(407) 740-0789

P.O. Box 865
Orlando, Florida 32802

Premium Content in Latest Medical News Denotes Premium Content in Latest Medical News